BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9619494)

  • 1. The stroke pharmacopeia: promising experimental therapies.
    Gengo FM
    Pharmacotherapy; 1998; 18(3 Pt 2):101S-107S; discussion 85S-86S. PubMed ID: 9619494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving therapeutic approaches to treating acute ischemic stroke.
    Weinberger JM
    J Neurol Sci; 2006 Nov; 249(2):101-9. PubMed ID: 17005205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pharmacologic strategies for acute neuronal injury.
    Luer MS; Rhoney DH; Hughes M; Hatton J
    Pharmacotherapy; 1996; 16(5):830-48. PubMed ID: 8888078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen free radical traps for the treatment of ischemia-associated organ injury.
    Jackson DM; Sammut IA
    Curr Opin Investig Drugs; 2004 Jan; 5(1):50-4. PubMed ID: 14983973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and investigational treatment options for ischemic stroke.
    Ryan M; Rhoney DH; Luer MS; Hatton J
    Pharmacotherapy; 1997; 17(5):959-69. PubMed ID: 9324184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenon as neuroprotectant in acute stroke?
    Altschuler EL
    Med Hypotheses; 2001 Feb; 56(2):227-8. PubMed ID: 11425293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of neuroprotection in acute ischemic stroke].
    Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
    Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of acute ischemic stroke.
    Rogers SJ; Sherman DG
    Clin Pharm; 1993 May; 12(5):359-76. PubMed ID: 8319420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of acute ischemic stroke.
    Besson G; Bogousslavsky J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S6-9. PubMed ID: 1726734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of cerebral ischemia.
    Ducruet AF; Grobelny BT; Zacharia BE; Hickman ZL; Yeh ML; Connolly ES
    Expert Opin Pharmacother; 2009 Aug; 10(12):1895-906. PubMed ID: 19514865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of neuroprotectants in stroke.
    Lyden P; Wahlgren NG
    J Stroke Cerebrovasc Dis; 2000 Nov; 9(6 Pt 2):9-14. PubMed ID: 17895214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posthypoxic reoxygenation-induced neurotoxicity prevented by free radical scavenger and NMDA/non-NMDA antagonist in tandem as revealed by dynamic changes in glucose metabolism with positron autoradiography.
    Murata T; Omata N; Fujibayashi Y; Waki A; Sadato N; Yoshimoto M; Wada Y; Yonekura Y
    Exp Neurol; 2000 Aug; 164(2):269-79. PubMed ID: 10915566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in cerebral ischemia: experimental approaches.
    Buchan A
    Neurol Clin; 1992 Feb; 10(1):49-61. PubMed ID: 1313534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute ischemic stroke therapy. A clinical overview.
    Onal MZ; Fisher M
    Eur Neurol; 1997; 38(3):141-54. PubMed ID: 9363826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute stroke. Emergency management and future interventions.
    Nassisi D
    Mt Sinai J Med; 1997; 64(4-5):241-8. PubMed ID: 9293725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
    Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update of neuroprotectants in clinical development for acute stroke.
    Lutsep H; Clark W
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1732-6. PubMed ID: 11892936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity.
    Kidd PM
    Altern Med Rev; 2009 Mar; 14(1):14-35. PubMed ID: 19364191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.